The current stock price of TLRY is 10.93 USD. In the past month the price increased by 1.2%. In the past year, price decreased by -13.25%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 48.3 | 1.00T | ||
| JNJ | JOHNSON & JOHNSON | 20.63 | 516.00B | ||
| MRK | MERCK & CO. INC. | 11.38 | 248.85B | ||
| PFE | PFIZER INC | 8.26 | 150.27B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.28 | 110.52B | ||
| ZTS | ZOETIS INC | 19.08 | 53.31B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.37 | 22.24B | ||
| VTRS | VIATRIS INC | 5 | 13.43B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.6 | 10.78B | ||
| CORT | CORCEPT THERAPEUTICS INC | 99.2 | 9.18B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.37B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 4.97B |
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
TILRAY BRANDS INC
265 Talbot Street West
Leamington ONTARIO V9X 1J2 CA
CEO: Irwin D. Simon
Employees: 2842
Phone: 15193228800
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in Leamington, Ontario and currently employs 2,842 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
The current stock price of TLRY is 10.93 USD. The price decreased by -10.04% in the last trading session.
TLRY does not pay a dividend.
TLRY has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
TILRAY BRANDS INC (TLRY) operates in the Health Care sector and the Pharmaceuticals industry.
TILRAY BRANDS INC (TLRY) has a market capitalization of 1.27B USD. This makes TLRY a Small Cap stock.
TILRAY BRANDS INC (TLRY) will report earnings on 2026-01-08, before the market open.
ChartMill assigns a technical rating of 2 / 10 to TLRY. When comparing the yearly performance of all stocks, TLRY is a bad performer in the overall market: 79.47% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to TLRY. Both the profitability and financial health of TLRY have multiple concerns.
Over the last trailing twelve months TLRY reported a non-GAAP Earnings per Share(EPS) of -13.2. The EPS decreased by -6498% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -103.13% | ||
| ROE | -139.41% | ||
| Debt/Equity | 0.18 |
16 analysts have analysed TLRY and the average price target is 17.2 USD. This implies a price increase of 57.4% is expected in the next year compared to the current price of 10.93.
For the next year, analysts expect an EPS growth of 99.61% and a revenue growth 3.65% for TLRY